![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
UK MHRA marketing authorization follows recent European Commission Marketing Authorization for LYTENAVA™ (bevacizumab gamma) in the EU for the treatment of wet AMDInitial commercial launches of...
Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Third Quarter of Fiscal 2024 on Wednesday, July 31, 2024, prior to the opening of trading on the New York...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 2.5632 | 1.13891248787 | 225.0568 | 230.24 | 222.76 | 898096 | 225.05185528 | CS |
4 | -0.25 | -0.109711677711 | 227.87 | 230.24 | 219.19 | 1135630 | 223.85856695 | CS |
12 | 3.99 | 1.7841971113 | 223.63 | 241.2195 | 214.7686 | 1459522 | 227.06298387 | CS |
26 | 8.44 | 3.85071630623 | 219.18 | 246.75 | 214.7686 | 1368624 | 231.42722178 | CS |
52 | 47.13 | 26.1122499861 | 180.49 | 246.75 | 171.65 | 1366001 | 215.27234553 | CS |
156 | 89.77 | 65.1215088865 | 137.85 | 246.75 | 135.18 | 1172803 | 204.30834464 | CS |
260 | 120.87 | 113.227166276 | 106.75 | 246.75 | 90.07 | 684242 | 177.3737088 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions